ZIM Laboratories Limited (ZIMLAB.NS)
INR 91.65
(1.15%)
INR 91.65
(1.15%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.08 Billion INR | 47.33% |
| 2022 | 1.41 Billion INR | -14.88% |
| 2021 | 1.65 Billion INR | 1.15% |
| 2020 | 1.64 Billion INR | -4.34% |
| 2019 | 1.71 Billion INR | -3.3% |
| 2018 | 1.77 Billion INR | 9.68% |
| 2017 | 1.61 Billion INR | 14.32% |
| 2016 | 1.41 Billion INR | -10.38% |
| 2015 | 1.57 Billion INR | -7.66% |
| 2014 | 1.7 Billion INR | 15.82% |
| 2013 | 1.47 Billion INR | 32.34% |
| 2012 | 1.11 Billion INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | -2.38 Billion INR | -214.74% |
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 2.08 Billion INR | 47.33% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 2.08 Billion INR | 0.0% |
| 2023 Q2 | 1.39 Billion INR | 0.0% |
| 2022 FY | 1.41 Billion INR | -14.88% |
| 2022 Q4 | 1.41 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 1.56 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 FY | 1.65 Billion INR | 1.15% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 1.58 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 1.65 Billion INR | 0.0% |
| 2020 Q2 | 1.71 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q4 | 1.64 Billion INR | 0.0% |
| 2020 FY | 1.64 Billion INR | -4.34% |
| 2019 FY | 1.71 Billion INR | -3.3% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q2 | 1.9 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q4 | 1.71 Billion INR | 0.0% |
| 2018 Q4 | 1.77 Billion INR | 0.0% |
| 2018 FY | 1.77 Billion INR | 9.68% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q2 | 1.79 Billion INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2017 Q1 | - INR | 0.0% |
| 2017 Q4 | 1.61 Billion INR | 0.0% |
| 2017 FY | 1.61 Billion INR | 14.32% |
| 2016 FY | 1.41 Billion INR | -10.38% |
| 2015 FY | 1.57 Billion INR | -7.66% |
| 2014 FY | 1.7 Billion INR | 15.82% |
| 2013 FY | 1.47 Billion INR | 32.34% |
| 2012 FY | 1.11 Billion INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Bajaj HealthCare Limited | 4.86 Billion INR | 57.253% |
| Hikal Limited | 12.99 Billion INR | 83.988% |
| Kilitch Drugs (India) Limited | 643.88 Million INR | -223.158% |
| Morepen Laboratories Limited | 4.45 Billion INR | 53.344% |
| Themis Medicare Limited | 1.88 Billion INR | -10.238% |
| Aarti Drugs Limited | 11.5 Billion INR | 81.913% |
| Albert David Limited | 1.15 Billion INR | -80.919% |
| Alembic Limited | 1.43 Billion INR | -45.294% |
| Alkem Laboratories Limited | 48.6 Billion INR | 95.719% |
| Alembic Pharmaceuticals Limited | 16.27 Billion INR | 87.214% |
| Bafna Pharmaceuticals Limited | 652.27 Million INR | -218.999% |
| Biofil Chemicals and Pharmaceuticals Limited | 288.79 Million INR | -620.488% |
| FDC Limited | 3.7 Billion INR | 43.903% |
| Glenmark Life Sciences Limited | 5.18 Billion INR | 59.838% |
| Gufic Biosciences Limited | 5.59 Billion INR | 62.842% |
| Hester Biosciences Limited | 3.59 Billion INR | 42.116% |
| Ind-Swift Laboratories Limited | 2.28 Billion INR | 9.116% |
| Ind-Swift Limited | 13.45 Billion INR | 84.533% |
| Innova Captab Limited | 4.89 Billion INR | 57.534% |
| IOL Chemicals and Pharmaceuticals Limited | 6.32 Billion INR | 67.123% |
| Jagsonpal Pharmaceuticals Limited | 296.76 Million INR | -601.16% |
| Jubilant Pharmova Limited | 61.27 Billion INR | 96.604% |
| Laurus Labs Limited | 42.71 Billion INR | 95.129% |
| Lupin Limited | 96.23 Billion INR | 97.838% |
| Mangalam Drugs & Organics Limited | 1.97 Billion INR | -5.285% |
| Medico Remedies Limited | 438.24 Million INR | -374.795% |
| Nectar Lifesciences Limited | 11.21 Billion INR | 81.452% |
| RPG Life Sciences Limited | 1.38 Billion INR | -50.758% |
| Solara Active Pharma Sciences Limited | 14.09 Billion INR | 85.234% |
| Sun Pharmaceutical Industries Limited | 183.56 Billion INR | 98.866% |
| Suven Pharmaceuticals Limited | 2.03 Billion INR | -2.288% |
| Unichem Laboratories Limited | 8.06 Billion INR | 74.214% |
| Vaishali Pharma Limited | 371.16 Million INR | -460.606% |
| Venus Remedies Limited | 1.39 Billion INR | -49.394% |
| Windlas Biotech Limited | 1.76 Billion INR | -18.044% |
| Lincoln Pharmaceuticals Limited | 1.07 Billion INR | -93.641% |
| Orchid Pharma Limited | 3.84 Billion INR | 45.871% |
| Procter & Gamble Health Limited | 2.56 Billion INR | 18.758% |
| Wanbury Limited | 3.15 Billion INR | 34.06% |
| Ipca Laboratories Limited | 33.74 Billion INR | 93.833% |
| Aarti Pharmalabs Limited | 8.25 Billion INR | 74.781% |
| Brooks Laboratories Limited | 248.6 Million INR | -736.989% |
| Eris Lifesciences Limited | 38.26 Billion INR | 94.563% |
| Sigachi Industries Limited | 2.53 Billion INR | 17.798% |
| Sakar Healthcare Limited | 1.26 Billion INR | -64.711% |
| Aurobindo Pharma Limited | 152.2 Billion INR | 98.633% |
| Divi's Laboratories Limited | 18.99 Billion INR | 89.043% |
| AstraZeneca Pharma India Limited | 3.66 Billion INR | 43.166% |
| Mankind Pharma Limited | 23.87 Billion INR | 91.285% |
| Sequent Scientific Limited | 8.27 Billion INR | 74.853% |
| Neuland Laboratories Limited | 5.49 Billion INR | 62.158% |
| J. B. Chemicals & Pharmaceuticals Limited | 10.7 Billion INR | 80.568% |
| Glenmark Pharmaceuticals Limited | 65.11 Billion INR | 96.804% |
| Zydus Lifesciences Limited | 71.79 Billion INR | 97.102% |
| Amrutanjan Health Care Limited | 783.82 Million INR | -165.463% |
| Wockhardt Limited | 39.87 Billion INR | 94.781% |
| Bal Pharma Limited | 2.51 Billion INR | 17.143% |
| Dr. Reddy's Laboratories Limited | 106.96 Billion INR | 98.055% |
| Bliss GVS Pharma Limited | 2.1 Billion INR | 1.332% |
| Par Drugs and Chemicals Limited | 159.79 Million INR | -1202.177% |
| Caplin Point Laboratories Limited | 3.5 Billion INR | 40.645% |
| Shilpa Medicare Limited | 12.93 Billion INR | 83.911% |
| Valiant Laboratories Limited | 1.05 Billion INR | -96.621% |
| Ajanta Pharma Limited | 10.71 Billion INR | 80.572% |
| Aarey Drugs & Pharmaceuticals Limited | 1.72 Billion INR | -20.821% |
| Granules India Limited | 22.95 Billion INR | 90.935% |
| Medicamen Biotech Limited | 940.36 Million INR | -121.271% |
| Syncom Formulations (India) Limited | 1.16 Billion INR | -78.574% |
| Piramal Enterprises Limited | 560.47 Billion INR | 99.629% |
| Torrent Pharmaceuticals Limited | 82.05 Billion INR | 97.464% |
| NATCO Pharma Limited | 10.53 Billion INR | 80.243% |
| Suven Life Sciences Limited | 148.62 Million INR | -1300.046% |
| Krebs Biochemicals & Industries Limited | 2.97 Billion INR | 30.033% |
| Strides Pharma Science Limited | 37.68 Billion INR | 94.478% |
| Indoco Remedies Limited | 10.34 Billion INR | 79.881% |
| Alpa Laboratories Limited | 307.12 Million INR | -577.503% |
| Lasa Supergenerics Limited | 541.92 Million INR | -283.958% |
| Sun Pharma Advanced Research Company Limited | 3.89 Billion INR | 46.55% |